Research Directory

Drugs for orphan diseases are no longer rare

Read more

Why patient-reported outcomes matter

Read more

Is an EU approval better than a hospital exemption?

Read more

Q1 2017 stock market report: Biotechs climb to the top of the tree

Read more

MedNous Briefing - The European Medicine Agency's PRIME Scheme

Read more

Immunotherapies start to transform cancer care

Read more

Targeting the tumour microenvironment

Read more

The Trump impact on healthcare M&A

Read more

WHO identifies bacteria posing the greatest threat

Read more

Bringing exhausted T cells back from the brink

Read more